Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer

University of California (UC) Davis

Status: Completed

Conditions: Cancer

Treatments: Behavioral: Telehealth visits; Behavioral: Standard of Care

Study type: Interventional

Funder types: Other

Identifiers

NCT04594096

1575166

Details and patient eligibility

About

This study will test the acceptability and feasibility of a telehealth intervention to improve communication between patients and medical providers in adolescent and young adult (AYA) cancer patients receiving chemotherapy treatment.

Enrollment: 20 patients

Sex: All

Ages: 12 to 29 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with cancer undergoing active treatment and who have received at least two cycles of chemotherapy
• Access to Epic MyChart (we will facilitate access to MyChart for interested patients who are not yet signed up)
• Access to a smartphone or tablet to access EPIC MyChart telehealth appointments

Exclusion criteria

• Non-English or non-Spanish speaking patients
• Potentially completing therapy during study period (including follow-up period) or plans to leave UCDCCC during study period

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

20 participants in 2 patient groups

Immediate Intervention Arm

Experimental group

Description:

Observation periods will be from 4 days post last administration of chemotherapy until the next chemotherapy administration. All patients will undergo an initial observation period that will span two chemotherapy cycles and will be receiving clinical care as usual determined by the primary oncology team. Patients enrolled on the immediate arm will start the intervention (telehealth visits) in Time Period 2 (following chemotherapy cycles 3 and 4). During Time Period 3 (following chemotherapy cycles 5 and 6), this arm will resume clinical care as usual.

Treatment:

Behavioral: Telehealth visits

Behavioral: Standard of Care

Delayed Intervention Arm

Experimental group

Description:

Observation periods will be from 4 days post last administration of chemotherapy until the next chemotherapy administration. All patients will undergo an initial observation period that will span two chemotherapy cycles and will be receiving clinical care as usual determined by the primary oncology team. Patients enrolled on the delayed arm will receive clinical care as usual during Time Period 2 (following chemotherapy cycles 3 and 4). During Time Period 3 (following chemotherapy cycles 5 and 6), this arm will start the intervention (telehealth visits).

Treatment:

Behavioral: Telehealth visits

Behavioral: Standard of Care